Erratum: Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: Discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone (Journal of Medicinal Chemistry (2011) 54 (7206-7219) DOI: 10.1021/jm200784m);Tricyclic series of heat shock protein 90 (HSP90) inhibitors part I: Discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the hsp90 molecular chaperone

Journal of Medicinal Chemistry

Volumn 54, Issue 20, 2011, Pages 7206-7219

  Vallée, François ^a   Carrez, Chantal ^a   Pilorge, Fabienne ^a   Dupuy, Alain ^a   Parent, Annick ^a   Bertin, Luc ^a   Thompson, Fabienne ^a   Ferrari, Paul ^a   Fassy, Florence ^a   Lamberton, Annabelle ^a   Thomas, Anne ^a   Arrebola, Rosalia ^a   Guerif, Stéphane ^a   Rohaut, Alexandre ^a   Certal, Victor ^a   Ruxer, Jean Marie ^a   Delorme, Cécile ^a   Jouanen, Alain ^a   Dumas, Jacques ^a   Grépin, Claudine ^a   Combeau, Cécile ^a   Goulaouic, Hélène ^a   Dereu, Norbert ^a   Mikol, Vincent ^a   Mailliet, Patrick ^a   Minoux, Hervé ^a   more..

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1[3 H IMIDAZO [4 5 C] PYRIDIN 2 YL] 3,4 DIHYDRO 2H PYRIDO [2,1 A] ISOINDOLE 6 ONE; ADENOSINE TRIPHOSPHATE; CHAPERONE; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; IMIDAZO [4,5 C] PYRIDINE DERIVATIVE; N [4(3H IMIDAZO [4,5 C] PYRIDIN 2 YL) 9H FLUOREN 9(R) YL] 1H PYRROLO [2,3 B] PYRIDINE 4 CARBOXAMIDE; PYRIDINE DERIVATIVE; RESORCINOL; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; BREAST CARCINOMA; CARCINOMA CELL; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IC 50; LOW THROUGHPUT SCREENING; MOUSE; NONHUMAN; PROTEIN INTERACTION; SYNTHESIS; VIRTUAL SCREENING;

EID: 80054905298     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm201675k     Document Type: Erratum

References (43)

1. Jolly, C.; Morimoto, R. I. Role of the heat shock response and molecular chaperones in oncogenesis and cell death J. Natl. Cancer Inst. 2000, 92, 1564-1572
2. Smith, D. F.; Whitesell, L.; Katsanis, E. Molecular chaperones: biology and prospects for pharmacological intervention Pharmacol. Rev. 1998, 50, 493-513 (Pubitemid 29028811)
3. Smith, D. F. Chaperones in signal transduction. In Molecular Chaperones in the Cell; Lund, P., Ed.; Oxford University Press: Oxford, 2001; pp 165-178.
4. Hanahan, D.; Weinberg, R. A. The hallmark of cancer Cell 2000, 100, 57-70
5. Whitesell, L.; Lundquist, S. L. Hsp90 and the chaperoning of cancer Nature Rev. Cancer 2005, 5, 761-572
6. Workman, P.; Burrows, F.; Neckers, L.; Rosen, N. Drugging the cancer chaperone Hsp90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress Ann. N. Y. Acad. Sci. 2007, 111, 202-216 (Pubitemid 350015011)
7. Janin, Y. L. Heat shock protein 90 inhibitors. A text book example of medicinal chemistry J. Med. Chem. 2005, 48, 7503-7512 (Pubitemid 41698792)
8. Janin, Y. L. ATPase inhibitors of Hsp90, second season Drug Discovery Today 2010, 15, 342-353
9. Patel, H. J.; Modi, S.; Chiosis, G.; Taldone, T. Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment Expert. Opin. Drug Discovery 2011, 6, 559-587
10. Kim, Y. S.; Alarcon, S. V.; Lee, S.; Lee, M.-J.; Giaccone, G.; Neckers, L.; Trepel, J. B. Update on Hsp90 inhibitors in clinical trial Curr. Top. Med. Chem. 2009, 9, 1479-1492
11. Trepel, J.; Mollapour, M.; Giaccone, G.; Neckers, L. Targeting the dynamic Hsp90 complex in cancer Nature Rev. Cancer 2010, 10, 537-549
12. Biamonte, M. A.; van de Water, R.; Arndt, J. W.; Scannevin, R. H.; Perret, D.; Lee, W. C. Heat shock protein 90: inhibitors in clinical trials J. Med. Chem. 2010, 53, 3-17
13. Loo, J. A. Studying noncovalent protein complexes by electrospray ionisation mass spectrometry Mass Spectrom. Rev. 1997, 16, 1-23 (Pubitemid 127583217)
14. Potier, N.; Barth, P.; Trisch, D.; Biellmann, J.-F.; van Dorsselaer, A. Study of non-covalent enzyme-inhibitor complexes of aldose reductase by electrospray mass spectrometry Eur. J. Biochem. 1997, 243, 274-282 (Pubitemid 27060412)
15. Gourves, J. P.; Couthon, H.; Sturtz, G. Synthesis of 3,4-dihydro-2 H -pyrido[1,2- b ]isoindol-1-one and 3,4-dihydro-2 H -pyrido[1,2- b ]pyrrolidin-1-one functionalized at the C-6 position by an intramolecular Horner-Wadsworth-Emmons reaction Eur. J. Org. Chem. 1999, 1999, 3489-3493
16. Deok-Chan, H.; Chang-Soo, Y.; Eunsun, Y. Reductive cyclization of N -iodoalkyl cyclic imides to nitrogen-fused polycyclic amides induced by samarium diiodide Tetrahedron Lett. 1996, 37, 2577-2580
17. Earl, R. A.; Volhardt, P. C. On the synthetic utility of thermally generated imines: the retro-ene imino Diels-Alder reaction Heterocycles 1982, 19, 265-271
18. Mazzochi, P. H.; Klingler, L.; Edwards, M.; Wilson, P.; Shook, D. Intra- and intermolecular Paterno-Büchi reactions on phthalimides. Isolation of the oxetane Tetrahedron Lett. 1983, 24, 143-146
19. Marion, F.; Courillon, C.; Malacria, M. Radical cyclization cascade involving ynamides: an original access to nitrogen-containing heterocycles Org. Lett. 2003, 5, 5095-5097 (Pubitemid 38073007)
20. Bacque, E.; Benard, D.; Bertin, L.; Carrez, C.; Mailliet, P.; Vallee, F. New isoindole derivatives, compositions containing same, preparation thereof and pharmaceuticals uses thereof in particular as inhibitors of chaperone protein HSP90 activities. Patent WO 2006 108948, 2006
21. Mailliet, P.; Bertin, L.; Guyon, T.; Thompson, F.; Ruxer, J.-M.; Pilorge, F.; Benard, D.; Minoux, H.; Carrez, C.; Goulaouic, H. Novel fluorene derivatives, composition containing said derivatives and the use thereof. Patent WO 2006 123061, 2006.
22. Zhou, V.; Han, S.; Brinker, A.; Klock, H.; Caldwell, J.; Gu, X.-J. A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors Anal. Biochem. 2004, 331, 349-357 (Pubitemid 38953086)
23. Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand efficiency: a useful metric for lead selection Drug Discovery Today 2004, 9, 430-431 (Pubitemid 38510559)
24. Drysdale, M. J.; Dymock, B. W.; Finch, H.; Webb, P.; McDonald, E.; James, K. E.; Cheung, K. M.; Mathews, T. P. Preparation of Isoxazoles as Inhibitors of Heat Shock Proteins. Patent WO 2004 72051, 2005.
25. Cox, P. J.; Majid, T. N.; Lai, J. Y. Q.; Morley, A.; Amendola, S.; Deprets, S. D.; Edlin, C.; Gardner, C. J.; Kominos, D.; Pedgrift, B. L.; Halley, F.; Gillepsy, T. A.; Edwards, M.; Clerc, F. F.; Nemecek, C.; Houille, O.; Damour, D.; Bouchard, H.; Bezard, D.; Carrez, C.; Azaindoles. Patent WO 2003 000688, 2003.
26. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 1997, 23, 3-25 (Pubitemid 27046991)
27. Jones, G.; Willett, P.; Glen, R. C. Molecular Recognition of Receptor Sites Using a Genetic Algorithm with a Description of Desolvation J. Mol. Biol. 1995, 245, 43-53
28. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and Validation of a Genetic Algorithm for Flexible Docking J. Mol. Biol. 1997, 267, 727-748 (Pubitemid 27170693)
29. Maestro, version 8.0; Schrödinger, LLC, New York, NY, 2007.
30. MacroModel, version 9.5; Schrödinger, LLC, New York, NY, 2007.
31. Jorgensen, W. L.; Tirado-Rives, J. The OPLS Force Field for Proteins. Energy Minimizations for Crystals of Cyclic Peptides and Crambin J. Am. Chem. Soc. 1988, 110, 1657-1666
32. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids J. Am. Chem. Soc. 1996, 118, 11225-11236 (Pubitemid 26399746)
33. Allen, F. H. The Cambridge Structural Database: a quarter of a million crystal structures and rising Acta Crystallogr., Sect. B: Struct. Sci. 2002, 58, 380-388 (Pubitemid 135702674)
34. Bruno, I. J.; Cole, J. C.; Edgington, P. R.; Kessler, M.; Macrae, C. F.; McCabe, P.; Pearson, J.; Taylor, R. New software for searching the Cambridge Structural Database and visualising crystal structures Acta Crystallogr., Sect. B: Struct. Sci. 2002, 58, 389-397 (Pubitemid 135702675)
35. Prodromou, C.; Piper, P. W.; Pearl, L. H. Expression and crystallization of the yeast Hsp82 chaperone, and preliminary X-ray diffraction studies of the amino-terminal domain Proteins 1996, 25, 517-522 (Pubitemid 26277730)
36. Collaborative Computational Project, No. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. 1994, 50, 760-763.
37. Brunger, A. T.; Adams, P. D.; Clore, G. M.; DeLano, W. L.; Gros, P.; Grosse-Kunstleve, R. W.; Jiang, J. S.; Kuszewsky, J.; Nilges, M.; Pannu, N. S.; Read, R. J.; Rice, L. M.; Simonson, T.; Warren, G. L. Crystallography and NMR system; a new sofware suite for macromoluclar structure determination Acta Crystallogr., Sect. D: Biol. Crystallogr. 1998, 54, 905-921
38. Bricogne, G. Direct phase determination by entropy maximization and likehood ranking: status report and perspectives Acta Crystallogr., Sect. D: Biol. Crystallogr. 1993, 49, 37-60
39. Emsley, P.; Cowtan, K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 2126-2132 (Pubitemid 41742764)
40. Chen, V. B.; Arendall, W. B., III; Headd, J. J.; Keedy, D. A.; Immormino, R. M.; Kapral, G. J.; Murray, L. W.; Richardson, J. S.; Richardson, D. C. MolProbity: all-atom structure validation for macromolecular crystallography Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 12-21
41. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank Nucleic Acids Res. 2000, 28, 235-242 (Pubitemid 30047768)
42. Llauger-Bufi, L.; Felts, S. J.; Huezo, H.; Rosen, N.; Chiosis, G. Synthesis of Novel fluorescent probes for the molecular chaperone Hsp90 Bioorg. Med. Chem. Lett. 2003, 13, 3975-3978 (Pubitemid 37338430)
43. Roehrl, M. H. A.; Wang, J. Y.; Wagner, G. A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization Biochemistry 2004, 43, 16056-16066 (Pubitemid 40041019)